MAU2 and acute lymphoblastic leukemia: Thereof, CdLS phenotypes were observed in one AML patient carrying NIPBL p.(G998E) (Case-92) and in one BCP-ALL patient harboring MAU2 p.(N410S) (Case-74) (Supplementary Table S2).